PP
PTX

Paloma Partners’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Paloma Partners’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-16,436
Closed -$74K – 2371
2016
Q2 		$74K Buy
+16,436
New +$107K ﹤0.01% 2093
2016
Q1 		– Sell
-1,538
Closed -$45K – 2219
2015
Q4 		$45K Buy
+1,538
New +$46.5K ﹤0.01% 1652

Other funds holding PTX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Paloma Partners's PTX Position: Q3 2016 in Review

Paloma Partners sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q3 2016, closing a stake of 16,436 shares — an estimated $74K sold.

Paloma Partners first reported a position in PTX in Q4 2015 and held it in 2 quarters. The position peaked at $74K in Q2 2016. 48 funds tracked by Wall St. Rank hold PTX as of Q3 2016.

  • Paloma Partners reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q3 2016 after selling out during the quarter.
  • Paloma Partners sold 16,436 Pernix Therapeutics Holdings, Inc. shares in Q3 2016, an estimated $74K.
  • Paloma Partners first reported a position in Pernix Therapeutics Holdings, Inc. in Q4 2015 and held it in 2 quarters.
  • Paloma Partners's Pernix Therapeutics Holdings, Inc. position peaked at $74K in Q2 2016.
  • 48 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q3 2016.

Based on Paloma Partners's 13F filing for Q3 2016, filed 14 Nov 2016.